Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

December 2013 - FRMC

Department

Conference Insider
12/18/2013

Tim Casey

Tim Casey
Patients with hemophilia who develop inhibitors had a lower frequency of hospitalizations and had costs 3 times lower than people who did not develop inhibitors.
Patients with hemophilia who develop inhibitors had a lower frequency of hospitalizations and had costs 3 times lower than people who did not develop inhibitors.
Patients with hemophilia who...
12/18/2013
First Report Managed Care
Conference Insider
12/18/2013

Tim Casey

Tim Casey
Patients who received interventions from their clinicians had improvements in adherence to their biologic therapies.
Patients who received interventions from their clinicians had improvements in adherence to their biologic therapies.
Patients who received...
12/18/2013
First Report Managed Care
Conference Insider
12/18/2013

Kerri Fitzgerald

Kerri Fitzgerald
The Strategic Reperfusion Early After Myocardial Infarction (STREAM) trial assessed ST-elevation myocardial infarction patients.
The Strategic Reperfusion Early After Myocardial Infarction (STREAM) trial assessed ST-elevation myocardial infarction patients.
The Strategic Reperfusion Early...
12/18/2013
First Report Managed Care
Conference Insider
12/18/2013

Kerri Fitzgerald

Kerri Fitzgerald
Dallas—After acute coronary syndrome (ACS) hospital discharge, patient adherence to medications is poor. By 1 month post-discharge, one-third of patients stop taking at least 1 medication prescribed, and by 1 year post-discharge, only...
Dallas—After acute coronary syndrome (ACS) hospital discharge, patient adherence to medications is poor. By 1 month post-discharge, one-third of patients stop taking at least 1 medication prescribed, and by 1 year post-discharge, only...
Dallas—After acute coronary...
12/18/2013
First Report Managed Care
Conference Insider
12/17/2013

Tim Casey

Tim Casey
Las Vegas—In the past 3 years, the FDA has approved 3 oral drugs to treat multiple sclerosis (MS): fingolimod in 2010, teriflunomide in 2012, and dimethyl fumarate in 2013. Still, the first-line treatment for the disease older therapies, such...
Las Vegas—In the past 3 years, the FDA has approved 3 oral drugs to treat multiple sclerosis (MS): fingolimod in 2010, teriflunomide in 2012, and dimethyl fumarate in 2013. Still, the first-line treatment for the disease older therapies, such...
Las Vegas—In the past 3 years,...
12/17/2013
First Report Managed Care
News Connection
12/17/2013

Kerri Fitzgerald

Kerri Fitzgerald
Under the provisions of the Patient Protection and Affordable Care Act (ACA), individuals with low or moderate incomes who purchase insurance from the new health exchanges are eligible for premium tax credits in order to afford the new...
Under the provisions of the Patient Protection and Affordable Care Act (ACA), individuals with low or moderate incomes who purchase insurance from the new health exchanges are eligible for premium tax credits in order to afford the new...
Under the provisions of the...
12/17/2013
First Report Managed Care
News Connection
12/17/2013

Jill Sederstrom

Jill Sederstrom
Men and women have a lower incidence of colorectal cancer if they also have a history of a negative sigmoidoscopy, negative colonoscopy, or polypectomy for adenoma, according to a new prospective analysis [N Engl J Med....
Men and women have a lower incidence of colorectal cancer if they also have a history of a negative sigmoidoscopy, negative colonoscopy, or polypectomy for adenoma, according to a new prospective analysis [N Engl J Med....
Men and women have a lower...
12/17/2013
First Report Managed Care
12/18/2013

Kerri Fitzgerald

Kerri Fitzgerald
For patients with heart failure and preserved left ventricular ejection fraction (HFpEF), there is no proven therapy to improve the prognosis.
For patients with heart failure and preserved left ventricular ejection fraction (HFpEF), there is no proven therapy to improve the prognosis.
For patients with heart failure...
12/18/2013
First Report Managed Care
12/18/2013

Kerri Fitzgerald

Kerri Fitzgerald
Dallas—Many practice guidelines—including the American Heart Association/American College of Cardiology and the European Society of Cardiology guidelines—recommend repairing or replacing the mitral-valve following a severe ischemic mitral...
Dallas—Many practice guidelines—including the American Heart Association/American College of Cardiology and the European Society of Cardiology guidelines—recommend repairing or replacing the mitral-valve following a severe ischemic mitral...
Dallas—Many practice...
12/18/2013
First Report Managed Care
Department
12/17/2013

Kerri Fitzgerald

Kerri Fitzgerald
Due to the lack of new gout treatments, no studies have been conducted to examine the benefit design and use for gout treatment.
Due to the lack of new gout treatments, no studies have been conducted to examine the benefit design and use for gout treatment.
Due to the lack of new gout...
12/17/2013
First Report Managed Care

Advertisement

Advertisement

Advertisement